Thoracoscopic Pleural Biopsy in Sohag University Hospital

Not Applicable

Recruiting

• Conditions: Pleural Diseases

• Registration Number: NCT06964308
• Lead Sponsor: Sohag University

Brief Summary

This study aims to evaluate the diagnostic efficacy, safety, and clinical outcomes of thoracoscopic pleural biopsy in the management of pleural diseases.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-10-01
• Status Verified: 2025-03
• Study First Submitted: 2025-03-16
• Study First Submitted QC: 2025-04-30
• Last Update Submitted: 2025-04-30
• Study First Posted: 2025-05-09
• Last Update Posted: 2025-05-09
• Primary Completion: 2025-05-30
• Study Completion: 2025-05-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

• Patients with suspected pleural disease who have been referred for thoracoscopic pleural biopsy
• Age: Adults aged 18 years and older
• Patients should have undergone necessary preoperative evaluations, including imaging studies (e.g., chest X-ray, CT scan) that indicate a need for biopsy.

Exclusion Criteria

• Contraindications to Thoracoscopic Biopsy: Patients with contraindications to thoracoscopic biopsy
• Infeasibility of Procedure: Patients with anatomical or physiological factors that make thoracoscopic biopsy technically unfeasible or unsafe (e.g., severe pleural adhesions or distorted anatomy).
• Alternative Diagnoses: Patients who have been definitively diagnosed with a condition that does not require thoracoscopic biopsy for further evaluation.
• Pregnancy: Pregnant women may be excluded due to potential risks to the fetus and the need for specific procedural considerations.
• Inability to Provide Consent: Patients who are unable to provide informed consent due to cognitive impairment, language barriers, or other reasons.
• Participation in Concurrent Studies: Patients currently participating in other clinical studies that could interfere with the outcomes of this study or affect their eligibility.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
early postoperative follow up for thoracoscopic pleural biopsy in the management of pleural diseases.	3 days after procedure	return to daily activity

Trial Locations

Locations (1)

Sohag University Hospital; 🇪🇬 Sohag, Egypt